Less Ads, More Data, More Tools Register for FREE

Pin to quick picksESKN.L Regulatory News (ESKN)

  • There is currently no data for ESKN

Director/PDMR Shareholding

16 Jun 2022 14:27

RNS Number : 1868P
Esken Limited
16 June 2022
 

 

 

 

 

 

 

17 June 2022

Esken Limited

 

 

("Esken" or the "Company")

 

 

Director/PDMR Shareholdings

Esken, the aviation and renewable energy group, announces that Nick Dilworth, who is a Director, and Charlotte Dilworth, a person closely associated with Mr Dilworth, have sold a total of 153 Ordinary Shares (at a price per share of £0.1023 for 97 shares and £0.1031 for 56 shares)) held in the name of a nominee account on their behalf to meet certain charges associated with that account. The number of shares held by Mr and Mrs Dilworth following the sale is 220,396 Ordinary Shares.

 

 

Esken Limited

Charlie Geller, Communications Director

C/O Tulchan Communications

Tulchan Communications

+44 207 353 4200

Olivia Peters / David Allchurch

esken@tulchangroup.com

 

 

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and person closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Dilworth

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Esken Limited

b)

LEI

213800BINQVRZFKA3E89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each in Esken Limited

 

 

 

 

ISIN: GB00B03HDJ73

b)

Nature of the transaction

Sale of Ordinary Shares in Esken Limited to cover broker administrative charges

c)

Price(s) and

volume(s)

Shares sold by nominee at £0.1023 per share

97

d)

Aggregated information

- Aggregated volume

 

 

 

 

- Price

Price(s)

Volume(s)

£0.1023

97

e)

Date of the transaction

16 June 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Charlotte Dilworth

2

Reason for the notification

a)

Position/status

Person closely associated with Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Esken Limited

b)

LEI

213800BINQVRZFKA3E89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each in Esken Limited

 

 

 

 

ISIN: GB00B03HDJ73

b)

Nature of the transaction

Sale of Ordinary Shares in Esken Limited to cover broker administrative charges

c)

Price(s) and

volume(s)

Shares sold by nominee at £0.1031 per share

56

d)

Aggregated information

- Aggregated volume

 

 

 

 

- Price

Price(s)

Volume(s)

£0.1031

56

e)

Date of the transaction

14 June 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEADKKFASAEFA
Date   Source Headline
21st Dec 20224:35 pmRNSPrice Monitoring Extension
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
15th Dec 20224:35 pmRNSPrice Monitoring Extension
8th Dec 20224:35 pmRNSPrice Monitoring Extension
1st Dec 20224:41 pmRNSSecond Price Monitoring Extn
1st Dec 20224:36 pmRNSPrice Monitoring Extension
29th Nov 20221:49 pmRNSResult of EGM
24th Nov 20224:35 pmRNSPrice Monitoring Extension
10th Nov 20227:00 amRNSTR-1
9th Nov 20227:00 amRNSInterim Results
9th Nov 20227:00 amRNSNotice of EGM
3rd Nov 20227:00 amRNSNotice of Results
19th Oct 202210:18 amRNSTR-1
12th Sep 20224:41 pmRNSSecond Price Monitoring Extn
12th Sep 20224:35 pmRNSPrice Monitoring Extension
12th Sep 202210:53 amRNSListing Rule 9.6.14(2) Disclosure
31st Aug 20227:00 amRNSTrading Statement
22nd Aug 20224:35 pmRNSPrice Monitoring Extension
10th Aug 20224:35 pmRNSPrice Monitoring Extension
5th Aug 202210:59 amRNSTR-1
28th Jul 20224:35 pmRNSPrice Monitoring Extension
13th Jul 20222:43 pmRNSAGM results
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20227:00 amRNSDirector/PDMR Shareholding
30th Jun 20227:00 amRNSAudit tender outcome and annual general meeting
23rd Jun 20224:35 pmRNSPrice Monitoring Extension
17th Jun 20224:41 pmRNSSecond Price Monitoring Extn
17th Jun 20224:37 pmRNSPrice Monitoring Extension
16th Jun 20222:27 pmRNSDirector/PDMR Shareholding
13th Jun 20224:36 pmRNSPrice Monitoring Extension
13th Jun 20223:28 pmRNSPosting of Annual Report and Notice of AGM
10th Jun 20224:36 pmRNSPrice Monitoring Extension
8th Jun 20224:35 pmRNSPrice Monitoring Extension
1st Jun 20224:36 pmRNSPrice Monitoring Extension
27th May 20224:40 pmRNSSecond Price Monitoring Extn
27th May 20224:35 pmRNSPrice Monitoring Extension
25th May 20227:00 amRNSFinal Results
18th May 20221:03 pmRNSDirector/PDMR Shareholding
18th May 20227:00 amRNSNotice of Results
12th May 20224:42 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
30th Mar 20224:35 pmRNSPrice Monitoring Extension
22nd Mar 20227:00 amRNSTrading Statement
11th Mar 20224:35 pmRNSPrice Monitoring Extension
4th Mar 20224:42 pmRNSSecond Price Monitoring Extn
4th Mar 20224:36 pmRNSPrice Monitoring Extension
23rd Feb 20227:00 amRNSAppointment of Joint Broker
18th Feb 20224:40 pmRNSSecond Price Monitoring Extn
18th Feb 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.